首页> 外文OA文献 >Systems biology coupled with label-free high-throughput detection as a novel approach for diagnosis of chronic obstructive pulmonary disease
【2h】

Systems biology coupled with label-free high-throughput detection as a novel approach for diagnosis of chronic obstructive pulmonary disease

机译:系统生物学与无标记高通量检测结合作为诊断慢性阻塞性肺疾病的新方法

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Chronic obstructive pulmonary disease (COPD) is a treatable and preventable disease state, characterised by progressive airflow limitation that is not fully reversible. Although COPD is primarily a disease of the lungs there is now an appreciation that many of the manifestations of disease are outside the lung, leading to the notion that COPD is a systemic disease. Currently, diagnosis of COPD relies on largely descriptive measures to enable classification, such as symptoms and lung function. Here the limitations of existing diagnostic strategies of COPD are discussed and systems biology approaches to diagnosis that build upon current molecular knowledge of the disease are described. These approaches rely on new 'label-free' sensing technologies, such as high-throughput surface plasmon resonance (SPR), that we also describe.
机译:慢性阻塞性肺疾病(COPD)是一种可治疗且可预防的疾病状态,其特征在于进行性气流受限并不能完全逆转。尽管COPD主要是肺部疾病,但现在人们认识到该疾病的许多表现都在肺部以外,导致人们认为COPD是一种全身性疾病。当前,COPD的诊断主要依靠描述性措施来分类,例如症状和肺功能。在此讨论了COPD现有诊断策略的局限性,并描述了基于当前疾病分子知识的系统生物学诊断方法。这些方法依赖于我们还介绍的新的“无标签”传感技术,例如高通量表面等离子体共振(SPR)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号